Peripheral stents will account for over $4.6 billion in worldwide sales by 2020, according to a new report from MedMarket Diligence. Critical limb ischemia, aortic aneurysm, chronic venous insufficiency and other pathologies continue to represent vertical and horizontal opportunities for medical technology (medtech) manufacturers, with expanded clinical applications and global growth. MedMarket Diligence has assessed the products, technologies and global markets for peripheral stenting systems in the 2016 report, Global Market Opportunities in Peripheral Arterial and Venous Stents, Forecast to 2020.

AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals in Harrisburg, Pa., in the ATLAS clinical study. This observational study explores the use of the AtriClip device to decrease complications associated with post-operative atrial fibrillation (POAF) by targeting specific cardiac surgery patient populations at the highest risk of developing POAF.

The Centers for Medicare & Medicaid Services (CMS) and America’s Health Insurance Plans (AHIP), as part of a broad Core Quality Measures Collaborative of healthcare system participants, released seven sets of clinical quality measures. These measures support multi-payer alignment, for the first time, on core measures primarily for physician quality programs. This work is informing CMS’s implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) through its measure development plan and required rulemaking.

February 17, 2016 — Up to 10 percent of people with high blood pressure have resistant hypertension — high blood ...

Apervita Inc. announced the American College of Cardiology (ACC) will add a recognized tool for predicting atherosclerotic cardiovascular disease (ASCVD) to the growing body of analytics being distributed through the Apervita Marketplace.